Please login or register first to view this content.
Topics
COVID-19 Infection Rates in the US Fall Short of Reaching Herd Immunity
Previous Infection and Antibiotic Use Linked to Guillain-Barré Syndrome
Helicobacter pylori Eradication Associated With Reduced Risk of Dyslipidemia
ACR Releases COVID-19 Vaccine Clinical Guidance for Patients With Rheumatic and Musculoskeletal Diseases
Clinical Outcomes of Women With and Without COVID-19 Giving Birth
AS03-Adjuvanted Flu Vaccine Increases Narcolepsy Incidence, Clinically Similar to Sporadic Cases
Prophylactic Effects of Dolutegravir in Infants With HIV Transmission Risk
Mental Health Impacts Observed Among the General Population During COVID-19
Effective Convalescent Plasma IgG Ratios Greater Than 18.45 to Ensure High Neutralizing Capacity
Outcome Disparities in Pediatric Sepsis By Ethnicity, Insurance Status
Janssen Single-Shot COVID-19 Vaccine Gets Emergency Use Authorization
Untreated Obstructive Sleep Apnea Linked to More Influenza Hospitalizations
Serum Cytokine Concentrations Early in COVID-19 Infection as Biomarker of Disease Severity
Individuals With Highest HIV Infection Rates Insured by Medicaid Less Likely to Persist With HIV Pre-Exposure Prophylaxis
Mucocutaneous Symptoms of Multisystem Inflammatory Syndrome in Pediatric Patients
Predictors of Immigrants’ Depression and Anxiety During COVID-19 Pandemic
People Living With HIV May Have Worse COVID-19 Outcomes
Updates to the 2021 Adult Immunization Schedule
Protection From HIV With Pre-Exposure Prophylaxis May be Accurately Assessed in Urine Samples
Pfizer-BioNTech COVID-19 Vaccine: New Storage Conditions Approved; Booster Dose Study Initiated
Uncertainty Remains for Long-Term Outcomes After Recovering from COVID-19
Brief, Patient-Reported Engagement Survey Associated With Virologic Control Among Patients With HIV
Expert Perspective: The Opioid Crisis and COVID-19
Are Cutaneous Manifestations Helpful for Diagnosing COVID-19?
COVID-19 Vaccine Efficacy After First Dose: Pfizer, Moderna, AstraZeneca
Is Liver Stiffness Seen in HIV Patients a Result of Hepatotoxic Drug Exposure?
Risk Score Predictive of Serious Infections in Patients With Rheumatoid Arthritis
Triple Therapy for Helicobacter pylori Eradication Safe for Adolescents
Chronic Use of Immunosuppressive Drugs Does Not Worsen COVID-19 Outcomes
Testing for Legionella Pneumonia in Those at Risk: Room for Improvement
Pfizer-BioNTech: COVID-19 Vaccine Trial in Pregnant Women Begins; New Storage Data Submitted to FDA
Suicide Prevention in the Context of COVID-19
JAK-inhibitor and Type I Interferon Possible Treatments for COVID-19
Healthy Microbiome Is Key to Sepsis Management
Comparing Rates of STIs in Men Before and After Starting HIV PrEP
FDA to Review 3-Antigen Prophylactic Hepatitis B Vaccine
High-Titer Convalescent Plasma Therapy Within 72 Hours of COVID-19 Symptoms Reduced Risk for Severe Illness
APPAC Trial: Uncomplicated Acute Appendicitis: Oral Antibiotics vs Intravenous Antibiotics?
ACIP: 2021 Child and Adolescent Immunization Schedule Updates
New Test for Diagnosis of Tuberculosis Meningitis in Patients With HIV
Meta-Analysis: SARS-CoV-2 Air Contamination in Hospitals
Azithromycin: Some Benefit to Pediatric Patients With HIV-Related Lung Disease
Risk and Severity of COVID-19 in Patients With Rheumatic Disorders Receiving DMARDs vs Methotrexate
Cabenuva Approved as First Long-Acting Injectable for HIV Treatment
Decline in Outpatient Antibiotic Prescriptions in Early Months of COVID-19
Mortality Rates for Pneumonia and Influenza Vary by Geographical Area
Pregnancy Experiences of Women With Rheumatic Diseases During the COVID-19 Pandemic
Use of E-cigarettes Among Youth in the United States Declines Early in COVID-19 Pandemic
Oxford-AstraZeneca COVID-19 Vaccine: New Study Results, Variant Coverage Update, Where Do We Stand?
-
Loading...
-
Loading...
Want to read more?
Next post in COVID19
